Literature DB >> 20595165

Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan.

L Kiakouama, V Cottin, B Etienne-Mastroïanni, C Khouatra, M Humbert, J F Cordier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595165     DOI： 10.1183/09031936.00004810

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

Review 1.  Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?

Authors:  Jason Weatherald; Laurent Savale; Marc Humbert
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

2.  Pulmonary hypertension in pulmonary langerhans cell granulomatosis.

Authors:  Matthias Held; Philipp Schnabel; Arne Warth; Berthold Jany
Journal:  Case Rep Med       Date:  2012-03-13

3.  Long-term improvement during tadalafil therapy in a patient with pulmonary hypertension secondary to pulmonary Langerhans cell histiocytosis.

Authors:  Kenji Nemoto; Shuji Oh-Ishi; Toshihide Inui; Mariko Nakazawa; Kentaro Hyodo; Masayuki Nakajima; Jun Kanazawa; Yukiko Miura; Takio Takaku; Yuko Minami; Kenji Hayashihara; Takefumi Saito; Yoshinori Kawabata
Journal:  Respir Med Case Rep       Date:  2016-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.